Team:Slovenia/Notebook/References

Abbas A.K., Lichtman A.H. 2004. Basic immunology: Functions and disorders of the immune system. 2nd edition. Philadelphia, PA: W. B. Saunders Co.: 323

Akira S., Takeda K. 2004. Toll like receptor signalling.

Nature reviews, Immunology, 4, 7: 499-511

Akira S., Takeda K. 2005. Toll like receptors in innate immunity.

International immunology, 17, 1: 1-14

Aras R.A., et al. 2003. Plasticity of repetitive DNA sequences within a bacterial (type IV) secretion system component.

The Journal of Experimental Medicine, 198, 9: 1349–1360

Baldari C.T., Lanzavecchia A., Telford J.L. 2005. Immune subversion by Helicobacter pylori.

Trends in Immunology, 26, 4: 199-207

Blander J.M. 2007. Signalling and phagocytosis in the orchestration of host defence.

Cellular Microbiology, 9, 2: 290–299

Blander J.M., Medzhitov R. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells.

Nature, 440, 6: 808-812

Blaser M.J., Atherton J.C. 2004. Helicobacter pylori persistence: biology and disease.

The Journal of Clinical Investigation, 113, 3: 321-333

Frenck RW, Clemens J. 2003. Helicobacter in the developing world.

Microbes and Infection, 5, 8: 705-13

Gangwer K. A. et. all. 2007. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain.

PNAS, 104, 41: 16293-16298

Galkin et al., 2008 Divergence of quaternary structures among bacterial flagellar filaments.

Science 320, 5874:382-5

Gewirtz A. T., Yu Y., Krishna U.S., Israel D.A., Lyons S.L., Peek R.M., Jr. 2004. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity.

The Journal of Infectious Diseases, 189, 10: 1914-20

Guy B. 2007. The perfect mix: recent progress in adjuvant research.

Nature reviews microbiology, 5, 7: 505-517

Hasan U.A. et al., 2004 .Differential induction of gene promoter constructs by constitutively active human TLRs

Biochem Biophys Res. Commun. 321, 124-131.

Israel D.A., Peek R.M. 2006. The Role of Persistence in Helicobacter pylori Pathogenesis.

Current Opininon in Gastroenterology, 22, 1: 3-7

Kanzler H. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature medicine, 13, 5: 552-559

Moran A.P., Aspinall G.O. 1998. Unique structural and biological features of Helicobacter pylori lipopolysaccharides.

Progress in clinical and biological research, 397: 37-49

Moran A.P., Lindner B., Walsh E. J. 1997. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides.

The Journal of Bacteriology, 179, 20: 6453-63

Nempont C. et. all. 2008. Deletion of Flagellin’s Hypervariable Region Abrogates Antibody-Mediated Neutralization and Systemic Activation of TLR5-Dependent Immunity.

The Journal of Immunology, 181, 3: 2036–2043

Querec T., Bennouna S., Alkan S., Laouar Y., Gorden K, Flavell R., Akira S., Ahmed R., Pulendran B. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

The Journal of Experimental Medicine, 203, 2: 413–424

Sansonetti P.J., Di Santo J.P. 2007. Debugging how Bacteria Manipulate the Immune Response.

Immunity 26, 2: 149–161

Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., Aderem A. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility.

Nature Immunology, 4, 12: 1247-53

Tevž et al. 2008. Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression.

Technology in cancer research and treatment, 7, 2: 91-101

Wirth H.P., Yang M., Peek R.M., Jr., Tham K.T., Blaser M.J. 1997. Helicobacter pylori Lewis expression is related to the host Lewis phenotype.

Gastroenterology, 113, 4: 1091-1098